{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:32:46Z","timestamp":1772195566612,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803799"],"award-info":[{"award-number":["81803799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11596-026-00168-x","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:29:29Z","timestamp":1770208169000},"page":"88-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Berberine Alleviates Pancreatic \u03b2-Cell Ferroptosis and\u00a0Injury in db\/db Mice by Regulating the\u00a0AGE\/RAGE Pathway: Insight from Proteomic Analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Xiao-cui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-ning","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-4244","authenticated-orcid":false,"given":"Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"3","key":"168_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diabet.2016.01.001","volume":"42","author":"M Hara","year":"2016","unstructured":"Hara M, Fowler JL, Bell GI, et al. Resting beta-cells\u2013A functional reserve? Diabetes Metab. 2016;42(3):157\u2013161.","journal-title":"Diabetes Metab."},{"issue":"7","key":"168_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Pasquali L, Cnop M. Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349\u2013362.","journal-title":"Nat Rev Endocrinol."},{"issue":"7","key":"168_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","volume":"19","author":"DL Eizirik","year":"2023","unstructured":"Eizirik DL, Szymczak F, Mallone R. Why does the immune system destroy pancreatic \u03b2-cells but not \u03b1-cells in type 1 diabetes Nat Rev Endocrinol. 2023;19(7):425\u2013434.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"168_CR4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2337\/dc19-0556","volume":"42","author":"Consortium R","year":"2019","unstructured":"Consortium R. Lack of durable improvements in \u03b2-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care. 2019;42(9):1742\u20131751.","journal-title":"Diabetes Care."},{"issue":"5","key":"168_CR5","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1210\/jc.2015-4202","volume":"101","author":"D Tripathy","year":"2016","unstructured":"Tripathy D, Schwenke DC, Banerji M, et al. Diabetes incidence and glucose tolerance after termination of pioglitazone therapy: results from ACT NOW. J Clin Endocrinol Metab. 2016;101(5):2056\u20132062.","journal-title":"J Clin Endocrinol Metab."},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"7526098","DOI":"10.1155\/2019\/7526098","volume":"2019","author":"N Li","year":"2019","unstructured":"Li N, Zhang H, Li X. Advances in research on the protective mechanisms of traditional Chinese medicine (TCM) in islet \u03b2 cells. Evid Based Complement Alternat Med. 2019;2019:7526098.","journal-title":"Evid Based Complement Alternat Med."},{"key":"168_CR7","unstructured":"Wang D, YE Z, Huang Q. Effect and Mechanism of Cortex Lycii Radicis Extracts on the Proliferation and Apoptosis of Pancreatic Beta Cell. J Zhejiang Chin Med Univ. 2015:478\u2013481."},{"key":"168_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/846742","volume":"2014","author":"Y Fu","year":"2014","unstructured":"Fu Y, Luo J, Jia Z, et al. Baicalein protects against type 2 diabetes via promoting islet \u03b2-cell function in obese diabetic mice. Int J Endocrinol. 2014;2014:846742.","journal-title":"Int J Endocrinol."},{"issue":"1","key":"168_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/JME-13-0302","volume":"53","author":"Z Li","year":"2014","unstructured":"Li Z, Shangguan Z, Liu Y, et al. Puerarin protects pancreatic \u03b2-cell survival via PI3K\/Akt signaling pathway. J Mol Endocrinol. 2014;53(1):71\u201379.","journal-title":"J Mol Endocrinol."},{"key":"168_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopha.2018.02.136","volume":"101","author":"Q Hu","year":"2018","unstructured":"Hu Q, Li Y, Liu C, et al. Effects of polysaccharide from Portulaca oleracea L. on voltage-gated Na+ channel of INS-1 cells. Biomed Pharmacother. 2018;101:572\u2013578.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"168_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2174\/1568026620666201022144405","volume":"21","author":"A Baska","year":"2021","unstructured":"Baska A, Leis K, Ga\u0142\u0105zka P. Berberine in the treatment of diabetes mellitus: a review. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1379\u20131386.","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"168_CR12","doi-asserted-by":"publisher","first-page":"9987097","DOI":"10.1155\/2021\/9987097","volume":"2021","author":"Y Han","year":"2021","unstructured":"Han Y, Xiang Y, Shi Y, et al. Pharmacokinetics and pharmacological activities of berberine in diabetes mellitus treatment. Evid Based Complement Alternat Med. 2021;2021:9987097.","journal-title":"Evid Based Complement Alternat Med."},{"issue":"1\u20133","key":"168_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ejphar.2008.12.056","volume":"606","author":"J Zhou","year":"2009","unstructured":"Zhou J, Zhou S, Tang J, et al. Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate\/high-fat diet-induced diabetic rats. Eur J Pharmacol. 2009;606(1\u20133):262\u2013268.","journal-title":"Eur J Pharmacol."},{"issue":"7","key":"168_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13258-022-01250-z","volume":"44","author":"M Li","year":"2022","unstructured":"Li M, She J, Ma L, et al. Berberine protects against palmitate induced beta cell injury via promoting mitophagy. Genes Genomics. 2022;44(7):867\u2013878.","journal-title":"Genes Genomics."},{"key":"168_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110137","volume":"127","author":"Z Ilyas","year":"2020","unstructured":"Ilyas Z, Perna S, Al-Thawadi S, et al. The effect of Berberine on weight loss in order to prevent obesity: a systematic review. Biomedecine Pharmacother. 2020;127:110137.","journal-title":"Biomedecine Pharmacother."},{"key":"168_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2024.131375","volume":"412","author":"Y Dong","year":"2024","unstructured":"Dong Y, Jiang Y, Sui M, et al. Linking proteomic function and structure to electroactive biofilms development across electrode orientations. Bioresour Technol. 2024;412:131375.","journal-title":"Bioresour Technol."},{"issue":"2","key":"168_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.12","volume":"1","author":"Y Ren","year":"2022","unstructured":"Ren Y, Yu G, Shi C, et al. Majorbio Cloud: a one-stop, comprehensive bioinformatic platform for multiomics analyses. Imeta. 2022;1(2):e12.","journal-title":"Imeta."},{"issue":"21","key":"168_CR18","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3390\/cells11213503","volume":"11","author":"C Du","year":"2022","unstructured":"Du C, Whiddett RO, Buckle I, et al. Advanced glycation end products and inflammation in type 1 diabetes development. Cells. 2022;11(21):3503.","journal-title":"Cells."},{"key":"168_CR19","doi-asserted-by":"publisher","first-page":"1126661","DOI":"10.3389\/fendo.2023.1126661","volume":"14","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhou S, Qiao L, et al. Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products. Front Endocrinol. 2023;14:1126661.","journal-title":"Front Endocrinol."},{"key":"168_CR20","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.1038\/ncomms13496","volume":"7","author":"MF Brereton","year":"2016","unstructured":"Brereton MF, Rohm M, Shimomura K, et al. Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic \u03b2-cells. Nat Commun. 2016;7:13496.","journal-title":"Nat Commun."},{"issue":"2","key":"168_CR21","doi-asserted-by":"publisher","first-page":"E268","DOI":"10.1152\/ajpendo.00314.2018","volume":"316","author":"MV Pinti","year":"2019","unstructured":"Pinti MV, Fink GK, Hathaway QA, et al. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. Am J Physiol Endocrinol Metab. 2019;316(2):E268\u2013E285.","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"3","key":"168_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, et al. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis. 2023;14(3):186.","journal-title":"Cell Death Dis."},{"key":"168_CR23","doi-asserted-by":"publisher","first-page":"3873420","DOI":"10.1155\/2022\/3873420","volume":"2022","author":"A Stancic","year":"2022","unstructured":"Stancic A, Saksida T, Markelic M, et al. Ferroptosis as a novel determinant of \u03b2-cell death in diabetic conditions. Oxid Med Cell Longev. 2022;2022:3873420.","journal-title":"Oxid Med Cell Longev."},{"issue":"1","key":"168_CR24","first-page":"6809703","volume":"2016","author":"AM Kay","year":"2016","unstructured":"Kay AM, Simpson CL, Stewart JA Jr. The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification. J Diabetes Res. 2016;2016(1):6809703.","journal-title":"J Diabetes Res."},{"issue":"8 Suppl 3","key":"168_CR25","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1097\/01.ASN.0000077414.59717.74","volume":"14","author":"S Sakurai","year":"2003","unstructured":"Sakurai S, Yonekura H, Yamamoto Y, et al. The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol. 2003;14(8 Suppl 3):S259\u2013S263.","journal-title":"J Am Soc Nephrol."},{"issue":"23","key":"168_CR26","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.3390\/molecules25235591","volume":"25","author":"CY Shen","year":"2020","unstructured":"Shen CY, Lu CH, Wu CH, et al. The development of Maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases. Molecules. 2020;25(23):5591.","journal-title":"Molecules."},{"key":"168_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","volume":"833","author":"D Sanajou","year":"2018","unstructured":"Sanajou D, Ghorbani Haghjo A, Argani H, et al. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Eur J Pharmacol. 2018;833:158\u2013164.","journal-title":"Eur J Pharmacol."},{"key":"168_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108519","volume":"206","author":"R Ramya","year":"2021","unstructured":"Ramya R, Coral K, Bharathidevi SR. RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells. Exp Eye Res. 2021;206:108519.","journal-title":"Exp Eye Res."},{"issue":"9","key":"168_CR29","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.apsb.2020.12.020","volume":"11","author":"G Tang","year":"2021","unstructured":"Tang G, Li S, Zhang C, et al. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B. 2021;11(9):2749\u20132767.","journal-title":"Acta Pharm Sin B."},{"key":"168_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","volume":"1243","author":"R Ramasamy","year":"2011","unstructured":"Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci. 2011;1243:88\u2013102.","journal-title":"Ann N Y Acad Sci."},{"issue":"2","key":"168_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Chen X, Zhou W, et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways. Acta Pharm Sin B. 2022;12(2):708\u2013722.","journal-title":"Acta Pharm Sin B."},{"issue":"4","key":"168_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3892\/mmr.2022.12656","volume":"25","author":"W Ge","year":"2022","unstructured":"Ge W, Jie J, Yao J, et al. Advanced glycation end products promote osteoporosis by inducing ferroptosis in osteoblasts. Mol Med Rep. 2022;25(4):140.","journal-title":"Mol Med Rep."},{"key":"168_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102559","volume":"59","author":"Y Li","year":"2023","unstructured":"Li Y, Qin M, Zhong W, et al. RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease. Redox Biol. 2023;59:102559.","journal-title":"Redox Biol."},{"issue":"1","key":"168_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41420-023-01477-z","volume":"9","author":"Y Gong","year":"2023","unstructured":"Gong Y, Liu Z, Zhang Y, et al. AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus. Cell Death Discov. 2023;9(1):178.","journal-title":"Cell Death Discov."},{"issue":"5","key":"168_CR35","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","volume":"57","author":"J Yin","year":"2008","unstructured":"Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712\u2013717.","journal-title":"Metabolism."},{"issue":"7","key":"168_CR36","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jc.2007-2404","volume":"93","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93(7):2559\u20132565.","journal-title":"J Clin Endocrinol Metab."},{"key":"168_CR37","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/DDDT.S409373","volume":"17","author":"S Dutta","year":"2023","unstructured":"Dutta S, Shah RB, Singhal S, et al. Metformin: a review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Devel Ther. 2023;17:1907\u20131932.","journal-title":"Drug Des Devel Ther."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00168-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:03:54Z","timestamp":1772190234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00168-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00168-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of Tongji Medical College, Huazhong University of Science and Technology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}